Gennex Laboratories Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 25	Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21

Sources of funds

Owner's fund

Equity share capital

22.74

22.74

18.02

12.65

12.65

Share application money

5.72

5.72

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

156.33

142.30

61.00

31.35

27.24

Loan funds

Secured loans

1.24

0.85

0.98

10.12

7.36

Unsecured loans

-

-

-

-

-

Total

186.04

171.61

80.00

54.12

47.25

Uses of funds

Fixed assets

Gross block

38.60

34.08

32.62

30.61

30.34

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

18.94

18.25

17.44

16.92

16.22

Net block

19.65

15.83

15.18

13.70

14.13

Capital work-in-progress

2.62

1.38

-

-

-

Investments

8.26

8.26

8.26

7.01

7.01

Net current assets

Current assets, loans & advances

187.84

179.87

72.78

47.50

37.95

Less : current liabilities & provisions

32.34

33.73

16.22

14.09

11.83

Total net current assets

155.50

146.13

56.56

33.41

26.12

Miscellaneous expenses not written

-

-

-

-

-

Total

186.04

171.61

80.00

54.12

47.25

Notes:

Book value of unquoted investments

8.26

-

8.26

7.01

7.01

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

0.98

1.96

0.74

0.74

1.70

Number of equity sharesoutstanding (Lacs)

2274.48

2274.48

1766.43

1265.03

1265.03